Keros Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Keros Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $151.06M.
- Keros Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $48.48M.
- Keros Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $9.68M.
- Keros Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $100.12M.
- Keros Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2024 was $151.06M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $151.06M 10-K · filed 2026-03-04 | |
| 2024-03-31 | $151.06M 10-Q · filed 2025-11-05 | |
| 2022-09-30 | $48.48M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $9.68M 10-Q · filed 2022-11-03 | |
| 2020-06-30 | $100.12M 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |